Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs.

This study looks at how the antibiotic cefepime is processed in the bodies of neonatal foals and adult dogs, determining that the same doses have different effects due to factors such as body weight.

Research Overview

In this scientific study, researchers are investigating the pharmacokinetics of a fourth-generation cephalosporin called cefepime. This essentially involves understanding how the drug gets absorbed, distributed, metabolized, and excreted within the bodies of neonatal foals and adult dogs.

Study Methodology

• Cefepime was given intravenously at a dose of 14 mg/kg to five neonatal foals and six adult dogs.
• Blood samples were then collected from both groups of animals.
• The researchers measured the plasma concentrations of cefepime using a method called reverse-phase high-performance liquid chromatography (HPLC).

A two-compartment pharmacokinetic model was used for describing cefepime concentrations.

Research Findings

• The elimination half-lives of cefepime were discovered to be 1.65 hours for the foal and 1.09 hours for the dog.
• The study tested if the pharmacokinetic parameters for cefepime could be scaled across species using principles of allometry.
• The parameters of elimination half-life, apparent volume of distribution, and systemic clearance were scaled linearly to body weight.
• This study also provided estimated doses of cefepime for treating bacteria sensitive to the drug in neonatal foals and dogs based on the pharmacokinetic values.

Implications

The results from this study essentially help us understand how cefepime behaves in different animal bodies – in this case, neonatal foals and dogs. This is important for determining appropriate dosage levels and interval times for administering the drug in these animals. It is particularly beneficial for veterinarians dealing with infections in newborn horses and dogs, providing guidelines for antibiotic use based on the size of the animal. As the study lined up with the principle of allometry, it supports the concept that drug metabolism can scale across different species based on body weight.